REQUEST A DEMO
Total
USD $0.00
Search more companies

Ipsum Clinical S.A.S "En Liquidacion" (Colombia)

Main Activities: Research and Development in the Physical, Engineering, and Life Sciences
Full name: Ipsum Clinical S.A.S "En Liquidacion" Profile Updated: September 14, 2022
Buy our report for this company USD 19.99 Most recent financial data: 2021 Available in: English & Spanish Download a sample report

Ipsum Clinical S.A.S "En Liquidacion" is a company based in Colombia, with its head office in Medellin. The enterprise currently operates in the Research and Development in the Physical, Engineering, and Life Sciences sector. It was established on January 21, 2015. Ipsum Clinical S.A.S "En Liquidacion" currently employs 6 (2022) people. In 2021, the company reported a net sales revenue increase of 399.88%. Its’ total assets recorded a growth of 264.83%.

Headquarters
Carrera 37 A 8 43 Ofc 901 Ed Rose Street
Medellin; Antioquia;

Contact Details: Purchase the Ipsum Clinical S.A.S "En Liquidacion" report to view the information.

Basic Information
Total Employees:
Purchase the Ipsum Clinical S.A.S "En Liquidacion" report to view the information.
Outstanding Shares:
Purchase the Ipsum Clinical S.A.S "En Liquidacion" report to view the information.
Incorporation Date:
January 21, 2015
Key Executives
Purchase this report to view the information.
Legal Representative
Company Performance
Financial values in the chart are available after Ipsum Clinical S.A.S "En Liquidacion" report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency COP. Absolute financial data is included in the purchased report.
Net sales revenue
399.88%
Total operating revenue
399.88%
Operating profit (EBIT)
N/A
Net Profit (Loss) for the Period
N/A
Total assets
264.83%
Total equity
N/A
Operating Profit Margin (ROS)
N/A
Net Profit Margin
N/A
Return on Equity (ROE)
341.24%
Quick Ratio
-0.1%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?